| Detected | Trial | Change |
|---|---|---|
| 2026-06-03 | NCT06550076 A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis |
date change Primary completion pushed: 2026-05-07 -> 2029-08-05 |
| 2026-06-03 | NCT06550076 A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis |
date change Completion pushed: 2026-05-07 -> 2029-08-05 |
| 2026-05-23 | NCT06764615 A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's… |
Primary endpoint(s) modified |
| 2026-05-23 | NCT06764615 A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's… |
Trial arms changed: 2 -> 3 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07286058 | Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis | Psoriatic Arthritis | Recruiting |
| NCT06671496 | A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been… | Psoriatic Arthritis | Recruiting |
| NCT07250802 | A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis | Plaque Psoriasis | Recruiting |
| NCT06671483 | A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic… | Psoriatic Arthritis | Recruiting |
| NCT06550076 | A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis | Plaque Psoriasis | Active, Not Recruiting |
| Phase 2 | |||
| NCT07244263 | A Study of Zasocitinib in Adults With Hidradenitis Suppurativa | Hidradenitis Suppurativa | Recruiting |
| NCT06233461 | A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of… | Crohn's Disease | Recruiting |
| NCT07108283 | A Study of Zasocitinib in Adults With Nonsegmental Vitiligo | Nonsegmental Vitiligo | Recruiting |
| NCT06764615 | A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's… | Crohn's Disease | Recruiting |
| NCT06254950 | A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of… | Ulcerative Colitis | Active, Not Recruiting |
| NCT07403968 | A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease | Crohn's Disease | Not Yet Recruiting |